Meet The Team
Dr Kimberly Rockley
PhD
Kimberly Rockley has a background in cell-based in vitro models and joined ApconiX to develop in vitro assays for early detection seizure liability. She holds a PhD in Pharmacy from Durham University where she used novel in vitro methods to investigate anthracycline-induced cardiotoxicity and its mitigation by perturbation of angiotensin signalling. Kim is passionate about the use of in vitro techniques to improve preclinical safety and reduce animal testing.
